Purchase Order 36C25523P0277
- Not listed
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard, a subsidiary of Becton, Dickinson and Company (BD). The contract, valued at $14,891.00, is for the delivery of three (3) vascular stents to support the VA's healthcare operations. The contract has an ultimate completion date of December 31, 2024 and does not utilize any set-aside designations. Bard is a manufacturer of a wide range of medical devices and...
- This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard. The contract, valued at $14,946.13, is for the delivery of three (3) vascular stents to support the VA's medical device needs. Bard is a subsidiary of Becton, Dickinson and Company (BD), a global medical technology manufacturer, and has been providing a range of medical devices and supplies to the...
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 15 (VISN 15), to C.R. Bard, Inc. (doing business as Bard), a subsidiary of Becton, Dickinson and Company (BD). The contract is for the delivery of two vascular stents, with a ceiling value of $10,162.79 and a period of performance ending on March 31, 2025. The contract does not have a set-aside designation, indicating that Bard competed for the...
- The Department of Veterans Affairs (VA) awarded a firm-fixed-price purchase order valued at $11,218.90 to C.R. Bard, Inc. (Bard) for the provision of vascular stents. Bard, a subsidiary of Becton, Dickinson and Company (BD), is a manufacturer of medical devices and supplies that has a longstanding history of providing products to federal agencies, including the VA and Department of Defense. The contract has an ultimate completion date of September 30, 2024 and was awarded on March 13, 2024. This...
- The Department of Veterans Affairs (VA) awarded a firm-fixed-price purchase order to C.R. Bard, Inc., operating as Bard, for the supply of vascular stents. The contract has a ceiling value of $14,891.80 and a completion date of September 30, 2024. Bard is a subsidiary of Becton, Dickinson and Company (BD), a global medical technology firm specializing in various medical devices, instruments, and supplies. Bard has a long history of providing healthcare products to federal agencies, including the...
- The Department of Veterans Affairs Veterans Health Administration awarded a $17,011 purchase order to C.R. Bard, Inc., doing business as Bard, for the delivery of vascular stents. As the prime contractor, Bard will supply the stents to Veterans Integrated Service Network 15 in support of its healthcare programs for veterans. Bard is a subsidiary of Becton, Dickinson and Company, doing business as BD. The firm fixed price contract runs from August 23, 2023 through December 31, 2023 for...
- This is a firm-fixed-price purchase order awarded to C.R. Bard, Inc., doing business as Bard, for the delivery of vascular stents. The contract was issued by the Veterans Integrated Service Network 15, which is a civilian agency of the U.S. Department of Veterans Affairs. The award has a ceiling value of $12,702.80 and a period of performance through December 31, 2024. Bard, a subsidiary of Becton, Dickinson and Company (BD), is an established manufacturer of medical devices and supplies that...
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 15 to C.R. Bard, Inc. (doing business as Bard), a subsidiary of Becton, Dickinson and Company. The contract is for the delivery of three vascular stents, with a total ceiling value of $15,000.00 and a period of performance ending on March 31, 2025. Bard is a for-profit organization and a manufacturer of various medical devices and supplies, including vascular stents,...
- This federal contract award, with a value of $11,427.90, was issued by the Department of Veterans Affairs (VA) to C.R. Bard, Inc., a subsidiary of Becton, Dickinson and Company (BD). The contract is for the procurement of prosthetic order stents, a type of medical device, with a performance period ending on December 31, 2024. This is a firm-fixed-price purchase order, and the contract does not have a set-aside designation, indicating that Bard competed for the award based on its capabilities...
- The U.S. Department of Veterans Affairs (VA), specifically through Veterans Integrated Service Network (VISN) 15, awarded a firm-fixed-price purchase order to C.R. Bard, Inc., doing business as Bard, for the delivery of three vascular stents. The contract has a ceiling value of $14,769.26 and an ultimate completion date of June 30, 2025. Bard is a subsidiary of Becton, Dickinson and Company (BD), a global medical technology manufacturer, and is registered as a for-profit organization in SAM.gov....
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard, a subsidiary of Becton, Dickinson and Company (BD). The $11,001.00 contract is for the delivery of STENTS and has an ultimate completion date of October 16, 2024. Bard is a manufacturer of medical devices, including vascular stents, surgical implants, catheters, and other specialized equipment used in healthcare settings. The contract was awarded through the VA's Veterans Integrated Service Network 15 (VISN 15) and does not have a set-aside designation, indicating it was competed on an open basis. As a parent company, BD has received numerous federal contract and grant awards from agencies such as the VA, Defense Logistics Agency, and Department of Health and Human Services to provide a wide range of medical devices, equipment, and supplies to support government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($327) | 10/16/24 | |
| Not listed | Not listed | $11.3k | 3/2/23 |